Clinical Trials Directory

Trials / Unknown

UnknownNCT04123132

Evaluation of Kinesophobia in Patients With Metabolic Syndrome

Status
Unknown
Phase
Study type
Observational
Enrollment
96 (estimated)
Sponsor
Erol Olcok Corum Training and Research Hospital · Academic / Other
Sex
All
Age
45 Years – 65 Years
Healthy volunteers
Accepted

Summary

Metabolic syndrome (MS) is a public health problem characterized by central obesity, increased blood pressure and triglyceride levels, decreased blood HDL levels and the presence of insulin resistance (1).Kinesiophobia is a fear of irrational movement that develops because of its belief in susceptibility to injury and is associated with low levels of physical activity. Considering that exercise improves metabolic processes in people with MS, we aimed to evaluate the presence of kinesophobia in patients with MS. Patients aged 45-65 years diagnosed with metabolic syndrome and healthy controls will be included in the study. Patients with rheumatic and neurological diseases,history of trauma, gonarthrosis, lumbar disc hernia, previous fractures, fibromyalgia and those who have experienced pain for the last week will be excluded. The participants will be filled in the Short Form-36 (SF-36), the Hospital Anxiety and Depression Scale, and the Tampa Kinesiophobia Scale. 48 patients with MS and 48 healthy participants will be included in the study.

Conditions

Interventions

TypeNameDescription
OTHERKinesiophobiaThe presence of kinesiofobia in patients with metabolic syndrome

Timeline

Start date
2019-09-25
Primary completion
2020-02-01
Completion
2020-02-01
First posted
2019-10-10
Last updated
2020-01-10

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04123132. Inclusion in this directory is not an endorsement.